Quest, Clinical Genomics Extend Deal for Colorectal Cancer Biomarkers
July 12, 2011
Quest, Clinical Genomics Extend Deal for Colorectal Cancer Biomarkers
Under the extension of a 2009 deal, Quest will make payments to Clinical Genomics to develop and validate molecular tests for the early detection of colorectal cancer.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.